Clover Corporation Limited (CLV) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Clover Corporation Limited.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.236 Good morning and thanks very much for joining us. 00:00:03.236 -- 00:00:07.882 Welcome to the Clover Corporation FY25 00:00:07.882 -- 00:00:10.363 results presentation. 00:00:10.386 -- 00:00:14.652 My name is Peter Davey and I'm the Managing Director and CEO of Clover. 00:00:14.652 -- 00:00:20.300 And with me is Andrew Allibon. Andrew is the CFO and Company Secretary. 00:00:20.300 -- 00:00:25.588 And we are very pleased to be taking you through some very good results. 00:00:25.588 -- 00:00:28.803 So it's lovely to be talking to you again this year. 00:00:28.803 -- 00:00:33.529 The first slide takes us just a bit of an overview of the company. 00:00:33.529 -- 00:00:38.876 Clover is a global leader in the microencapsulation of Omega-3s and we service 00:00:38.876 -- 00:00:42.822 the infant formula and food market. 00:00:42.822 -- 00:00:48.529 We are in infant formula, we are in functional food and beverage and pharmaceuticals 00:00:48.529 -- 00:00:53.356 and supplements and certainly over the last 12 to 18 months we've seen a significant 00:00:53.356 -- 00:00:55.356 differentiation 00:00:55.378 -- 00:01:00.503 of our products into alternative markets. Our manufacturing footprint is across 00:01:00.503 -- 00:01:04.727 Australia, New Zealand and Ecuador and later in the presentation I'll talk you through 00:01:04.727 -- 00:01:08.831 our vertical integration strategy and how that's servicing the business. 00:01:08.831 -- 00:01:13.274 We have just over 68 employees and 00:01:13.756 -- 00:01:16.079 we use 00:01:16.079 -- 00:01:19.642 vertical integration of the business into other suppliers that provide us with a lot 00:01:19.642 -- 00:01:24.862 of services so it's a fairly light business in terms of the amount of employees we have. 00:01...